Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History NBIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics NBIX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 29.12.1995

Neurocrine Biosciences Inc

NBIX
Current price
132.02 USD -2.92 USD (-2.16%)
Last closed 134.11 USD
ISIN US64125C1099
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 13 065 464 832 USD
Yield for 12 month -9.38 %
1Y
3Y
5Y
10Y
15Y
NBIX
21.11.2021 - 28.11.2021

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California. Address: 12780 El Camino Real, San Diego, CA, United States, 92130

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

160.19 USD

P/E Ratio

44.75

Dividend Yield

Financials NBIX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures NBIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+2 355 300 000 USD

Last Year

+1 887 100 000 USD

Current Quarter

+572 600 000 USD

Last Quarter

+627 700 000 USD

Current Year

+2 321 300 000 USD

Last Year

+1 847 400 000 USD

Current Quarter

+563 400 000 USD

Last Quarter

+618 400 000 USD
EBITDA 529 900 000 USD
Operating Margin TTM 4.14 %
Price to Earnings 44.75
Return On Assets TTM 8.75 %
PEG Ratio 0.27
Return On Equity TTM 12.43 %
Wall Street Target Price 160.19 USD
Revenue TTM 2 412 600 064 USD
Book Value 25.61 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.10 %
Dividend Yield
Gross Profit TTM 1 542 000 000 USD
Earnings per share 2.95 USD
Diluted Eps TTM 2.95 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -81.10 %
Profit Margin 12.68 %

Stock Valuation NBIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 44.75
Forward PE 26.04
Enterprise Value Revenue 5.30
Price Sales TTM 5.42
Enterprise Value EBITDA 22.84
Price Book MRQ 5.23

Technical Indicators NBIX

For 52 Weeks

84.23 USD 157.98 USD
50 Day MA 123.74 USD
Shares Short Prior Month 3 495 103
200 Day MA 121.92 USD
Short Ratio 3.39
Shares Short 3 534 131
Short Percent 4.72 %